全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Sensory–motor rehabilitation therapy for task

DOI: 10.1177/1758998318764219

Keywords: Musicians’ dystonia,writers’ dystonia,sensory–motor rehabilitation therapy,hand therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Medical treatments have limited long-term effect in task-specific dystonia. Whilst evidence supports the use of rehabilitation, no randomised controlled trials have been undertaken. This small-scale study determined the feasibility of implementing and evaluating a mixed sensory–motor task-specific dystonia rehabilitative programme. Participants with writer’s or musician’s dystonia were recruited from a movement disorder and hand therapy clinic. Feasibility measures were recruitment rate, retention, session attendance, adherence to exercises. Self-report measures at 0, 3 and 6 months included: Arm Dystonia Disability Scale (ADDS), Tubiana and Chamagne Scale (TCS), Brief Illness Perception Questionnaire (BIPQ), Health Status (EQ-5D 5L), Clinical Global Impression Scale (CGI). Task performance was video-recorded at baseline and 6 months. At 6 months, interviews explored participant experiences of the intervention. Fifteen patients were recruited over 6 months (rate 2.5/month, musician’s dystonia?=?8, writer’s dystonia?=?7). Complete data sets were collected for twelve people(80%). The programme comprised a maximum six sessions plus daily home exercises. Nine completed the home programme at ≥75%. No adverse events were reported. Effect sizes at 3 and 6 months, respectively, were ADDS 3-month?=?0.28, 6-month?=?0.23; TCS 3-month?=?0.13, 6-month?=?0.53; BIPQ 3-month?=?0.38, 6-month?=?0.71; EQ-5D-5L 3-month?=?0.34, 6-month?=?0.59; video analysis at 6 months?=?0.78. Eleven (92%) improved on the CGI. Interviews supported acceptability of the intervention. This intervention was feasible to deliver with high retention, adherence and acceptability. Improvements occurred across measures. This informs the development of future randomised controlled trials

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133